Company Data

Autolus Therapeutics plc

Ticker
AUTL
Current Price
$1.5 -4.46%
Market Cap
$399.2M
Price Target
Refer to Report
Volume
2.1M
52wk Range
$1.105 - $5
Advanced Market Data

Overview

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer. The company’s clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy